Frontlight ResearchEarly access
CompletedNo phase
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
Key facts
- Who runs it
- University of Vermont
- Where
- Asheville, Burlington, Chapel Hill, and Richmond, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 88 people enrolled
- Started
- 8 Aug 2019
- Ended
- 1 Feb 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Medically-supervised withdrawal
- Opioid agonist treatment
- Comprehensive clinical care
- Record updated
- 8 February 2024
Who can take part
- Age
- 18 years to 41 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Be ages 18 to 41, inclusive
- Have a single fetus pregnancy between 6-30 weeks estimated gestational age
- Willing to participate in the study
Who cannot take part
- Non-English speaking
Where in United States
- Mountain Area Health Education CenterAsheville, United States
- University of VermontBurlington, United States
- UNC Chapel Hill HorizonsChapel Hill, United States
- Virginia Commonwealth UniversityRichmond, United States
About the trial
What the trial wants to find out
This study will compare medically-supervised withdrawal (MSW, 'detoxification') to opioid agonist treatment (OAT, 'maintenance') with buprenorphine for pregnant women with opioid use disorder in terms of maternal, fetal, and neonatal outcomes. Outcomes will be assessed during pregnancy, at birth and for 12 months postpartum. This study has the potential to impact health service policy and practices in terms of the treatment options of pregnant women with opioid use disorder.
The 2 groups in the trial
- Medically-supervised withdrawal (MSW)
Treatment: Medically-supervised withdrawal and Comprehensive clinical care
- Opioid agonist treatment (OAT)
Treatment: Opioid agonist treatment and Comprehensive clinical care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Medically-supervised Withdrawal vs. Agonist Maintenance in the Treatment of Pregnant Women With Opioid Use Disorder: Maternal, Fetal, and Neonatal Outcomes
- Record updated
- 8 February 2024